Evidence map›Paper›PMID 12654790›Full record

ArticleInfection and immunity2003

Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth.

S Worku, D F Hoft

Abstract readEvaluation Study
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Article
  6. Th9 cells provide protective TB immunity.Frontiers in immunology · 2025
    Article
  7. Vγ9Vδ2 T cells expanded with vitamin C combined with HMBPPFrontiers in cellular and infection microbiology · 2025
    Article
  8. Assays for AssessingPathogens (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Review
  11. Frontiers in veterinary science · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Ion Transport Modulators as Antimycobacterial Agents.Tuberculosis research and treatment · 2020
    Article
  16. BCG Vaccination InducesFrontiers in immunology · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S WorkuDepartment of Internal Medicine, Saint Louis University Center for Vaccine Development, St. Louis, MO 63110, USA.
D F Hoft
Saint Louis University · US

Funding

CONTROL MEASURES IN AGING AND INFECTIOUS DISEASEN01AI45250 · NIAID · PI ROBERT B, BELSHE · 2007 to 2007
$4.0M
AIDS VACCINE EVALUATION UNITSN01AI045211 · NIAID · SAINT LOUIS UNIVERSITY · PI BELSHE, ROBERT B. · 1994 to 2000
$52k
CONTROL MEASURES IN AGING AND INFECTIOUS DISEASE-266945250N01AI045250 · NIAID · SAINT LOUIS UNIVERSITY · 1994 to 2003
$0k
NIAID NIH HHS N01 AI045250NIAID NIH HHS N01 AI 45211NIAID NIH HHS N01 AI 45250
6 · The paper itself

Abstract

We investigated the effects of peripheral blood mononuclear cells expanded with irrelevant control and mycobacterial antigens on the intracellular growth of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in human macrophages. More than 90% of the cells present after 1 week of in vitro expansion were CD3(+). T cells were expanded from purified protein derivative-negative controls, persons with latent tuberculosis, and BCG-vaccinated individuals. T cells expanded with nonmycobacterial antigens enhanced the intracellular growth of BCG in suboptimal cultures of macrophages. T cells expanded with live BCG or lysates of Mycobacterium tuberculosis directly inhibited intracellular BCG. Recent intradermal BCG vaccination significantly enhanced the inhibitory activity of T cells expanded with mycobacterial antigens (P < 0.02), consistent with the induction of memory-immune inhibitory T-cell responses. Selected mycobacterial antigens (Mtb41 > lipoarabinomannan > 38kd > Ag85B > Mtb39) expanded inhibitory T cells, demonstrating the involvement of antigen-specific T cells in intracellular BCG inhibition. We studied the T-cell subsets and molecular mechanisms involved in the memory-immune inhibition of intracellular BCG. Mycobacteria-specific gammadelta T cells were the most potent inhibitors of intracellular BCG growth. Direct contact between T cells and macrophages was necessary for the BCG growth-enhancing and inhibitory activities mediated by control and mycobacteria-specific T cells, respectively. Increases in tumor necrosis factor alpha, interleukin-6, transforming growth factor beta, and vascular endothelial growth factor mRNA expression were associated with the enhancement of intracellular BCG growth. Increases in gamma interferon, FAS, FAS ligand, perforin, granzyme, and granulysin mRNA expression were associated with intracellular BCG inhibition. These culture systems provide in vitro models for studying the opposing T-cell mechanisms involved in mycobacterial survival and protective host immunity.

Indexed as

AdolescentAdultAntigens, BacterialBCG VaccineCells, CulturedCoculture TechniquesHumansImmunologic MemoryLeukocytes, MononuclearLymphocyte ActivationMacrophagesMiddle AgedMycobacterium bovisMycobacterium tuberculosisReceptors, Antigen, T-Cell, gamma-deltaT-Lymphocyte SubsetsAntigens, BacterialBCG VaccineReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID12654790
PMCPMC152055
OpenAlexW2118726984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.